US Stock MarketDetailed Quotes
ALVO Alvotech
- 12.890
- +0.090+0.70%
Close Apr 18 16:00 ET
3.60BMarket Cap-5304P/E (TTM)
12.950High12.720Low90.15KVolume12.720Open12.800Pre Close1.16MTurnover0.10%Turnover RatioLossP/E (Static)279.57MShares18.00052wk High-3.87P/B1.12BFloat Cap6.70052wk Low--Dividend TTM87.07MShs Float18.000Historical High--Div YieldTTM1.80%Amplitude5.200Historical Low12.875Avg Price1Lot Size
About Alvotech Company
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman on August 23, 2021 and is headquartered in Luxembourg.
Company Profile
SymbolALVO
Company NameAlvotech
Listing DateJun 16, 2022
Founded2018
CEOMr. Robert Wessman
MarketNASDAQ
Employees999
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address9, rue de Bitbourg
CityLuxembourg
ProvinceLuxembourg
CountryLuxembourg
Zip Code1273
Phone352-422-4500
Websitehttp://www.alvotech.com
Company Executives
- Name
- Position
- Salary
- Robert Wessman
- Executive Chairman of the Board and Chief Executive Officer
- --
- Joel Morales
- Chief Financial Officer
- --
- Joseph E. McClellan
- Chief Scientific Officer
- --
- Richard Davies
- Deputy Chairman of the Board
- --
- Ann Merchant
- Director
- --
- Tomas Ekman
- Director
- --
- Lisa Graver
- Director
- --
- Faysal Kalmoua
- Director
- --
- Arni Hardarson
- Director
- --
- Linda McGoldrick
- Director
- --
- Zharov Tanya
- General Counsel
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg